TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro

SurfGraphPro, an AI tool, transforms complex protein structures into an easy-to-analyze format that helps researchers quickly identify binding sites, predict molecular interactions and understand protein behavior with greater speed and scalability than traditional approaches. By combining 3D surface graph representations with advanced machine learning, this technology from Los Alamos National Laboratory reduces the computational burden of protein analysis while preserving the structural detail needed for high-value applications in drug discovery, antibody design, pathogen detection and custom protein engineering.

The Challenge: Protein surfaces are extremely complex, three-dimensional structures, and that complexity makes them difficult to analyze using traditional computational approaches. In practice, many existing methods rely on hand-selected biochemical features, expensive calculations or narrow task-specific models that do not generalize well to new questions. As a result, researchers can face slow runtimes, limited scalability and incomplete insight when trying to identify binding sites, predict molecular interactions or understand broader protein behavior across large sets of proteins.

These limitations can make it difficult to move quickly from protein structure data to useful predictions in areas such as drug discovery, antibody design, pathogen detection and protein engineering.

Problems Solved: SurfGraphPro solves these problems by converting protein surfaces into a graph-based representation that preserves both the physical shape of the surface and the biochemical information carried by surface-exposed amino acids. This tool gives machine learning models a more efficient and flexible way to process protein structures without requiring repeated manual feature engineering or highly specialized analysis pipelines for each new use case. By reducing computational burden while keeping the key structural details needed for prediction, SurfGraphPro makes it possible to analyze proteins more quickly, at larger scale and across a wider range of applications.

This approach includes identifying likely binding sites, estimating molecular compatibility, supporting drug screening efforts, improving antibody and protein design workflows, and enabling other protein-focused prediction tasks where speed, scalability and adaptability matter.

Key Advantages: Helps turn complex protein structures into information computers can use more easily Speeds up protein analysis compared with older approaches Reduces the amount of manual feature engineering needed Preserves important details about both protein shape and chemical properties Supports multiple uses, including drug discovery, antibody design and pathogen detection Offers a flexible platform that can be adapted to different protein-related tasks Market Applications: Pharmaceuticals and Biotechnology (drug discovery, target screening, protein optimization) Biologics and Antibody Development (antibody engineering, binding analysis, therapeutic design) Diagnostics and Infectious Disease (pathogen detection, biomarker analysis, assay development) Agricultural Biotechnology (protein analysis, crop trait research, bio-based product development) Materials and Industrial Science (protein-mineral interaction studies, polymer compatibility, bio-inspired materials) Research Tools and Software (protein modeling, computational biology, prediction platforms) Development Status: TRL 3 US Patent pending LA-UR-26-23589 LANL Tech Partnerships: Unlock the Innovative Potential Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products. LANL's licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements.

For specific discussions, please contact [email on the source notice].

Note: This is not a call for external services for the development of this technology. https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology m.lanl.gov/tech-search